Medical information Clinical review pending

Genetic Testing

Cryptococcus Neoformans Detection PCR Test

Detects the presence of Cryptococcus neoformans fungus using PCR technology. This test is crucial for diagnosing infections, especially in individuals with weakened immune systems. Confirm with the laboratory before booking.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube, 1 mL CSF/Sputum/Fluids in a sterile screw-capped container, or Tissue in normal saline.
Results: Confirm with the laboratory before booking.
Preparation: No special preparation is required prior to testing. Samples should be shipped refrigerated and must not be frozen.

Test priceKSh 26,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Cryptococcus Neoformans Detection PCR Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Suspected cryptococcal meningitis
✓Symptoms suggestive of cryptococcosis (e.g., fever, headache, confusion)
✓Immunocompromised patients (e.g., HIV/AIDS, transplant recipients)
✓Monitoring treatment response in known cases
✓Diagnosis in patients with pulmonary or disseminated cryptococcosis

In plain language

What this test helps you understand

This test aids in the diagnosis of cryptococcosis, a fungal infection caused by Cryptococcus neoformans. It is particularly useful in immunocompromised patients where early detection is critical for effective treatment and management.

The Cryptococcus Neoformans Detection PCR Test is a highly sensitive diagnostic tool used to identify Cryptococcus neoformans, a fungus that can cause serious infections, particularly in people with compromised immune systems like those living with HIV/AIDS. Early diagnosis and management of cryptococcal infections are vital, as they can become life-threatening if not treated promptly. This test helps in the timely identification of the fungus. It measures the genetic material of Cryptococcus neoformans in samples such as blood, cerebrospinal fluid (CSF), sputum, or tissue. The test uses polymerase chain reaction (PCR) technology to amplify the fungus's DNA, enabling accurate detection even in small amounts. This test is recommended for individuals experiencing symptoms like severe headache, fever, confusion, or respiratory issues. It is also advised for those at higher risk, including individuals with HIV/AIDS, organ transplant recipients, or those undergoing immunosuppressive therapy. Benefits include early detection, accurate diagnosis due to high sensitivity and specificity, and guidance for effective treatment planning. Results indicate the presence or absence of the fungus in the sample. A positive result requires immediate medical attention. Confirm with the laboratory before booking.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo special preparation is required prior to testing. Samples should be shipped refrigerated and must not be frozen.

Sample4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube, 1 mL CSF/Sputum/Fluids in a sterile screw-capped container, or Tissue in normal saline.

MethodologyPolymerase Chain Reaction (PCR) technology is used to amplify and detect the genetic material (DNA) of Cryptococcus neoformans.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test detects the presence of Cryptococcus neoformans DNA. It does not differentiate between live and dead organisms. A negative result does not completely rule out infection, especially if clinical suspicion is high. Confirm with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

Cryptococcus neoformans is a type of fungus that can cause infections, particularly in people with weakened immune systems. Infections can affect the lungs or central nervous system (brain and spinal cord).

This test is recommended for individuals with symptoms suggestive of cryptococcosis, such as severe headache, fever, or confusion, especially if they have a weakened immune system (e.g., due to HIV/AIDS, organ transplant, or certain medications).

Samples can include blood, cerebrospinal fluid (CSF), sputum, or tissue. Your doctor will determine the appropriate sample based on your symptoms and medical history.

PCR tests are generally highly sensitive and specific, meaning they are good at detecting the fungus when present and minimizing false positives. However, no test is 100% accurate.

A positive result indicates the presence of Cryptococcus neoformans DNA in the sample, suggesting an infection. A negative result suggests the fungus was not detected. Your doctor will interpret the results in the context of your overall health.

Turnaround time varies. Please confirm the expected turnaround time with the laboratory before booking your test.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp